<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44">
 <label>44.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Caly</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Druce</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Catton</surname>
    <given-names>MG</given-names>
   </name>
   <name>
    <surname>Jans</surname>
    <given-names>DA</given-names>
   </name>
   <name>
    <surname>Wagstaff</surname>
    <given-names>KM.</given-names>
   </name>
  </person-group>
  <article-title>The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [published online ahead of print, 2020 Apr 3].</article-title>
  <source>
   <italic>Antiviral Res.</italic>
  </source> (
  <year>2020</year>) 
  <volume>178</volume>:
  <issue>104787</issue>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104787</pub-id>
  <?supplied-pmid 32251768?>
  <pub-id pub-id-type="pmid">32251768</pub-id>
 </mixed-citation>
</ref>
